Table 1.
Variablea | Value |
---|---|
Mean (SD) | |
Age, y | 14.5 (1.6) |
K-SADS depression scale ratingb | 28.6 (9.4) |
K-SADS mania scale ratingb | 24.3 (9.5) |
CGAS rating26 | |
Current (last 2 wk) | 57.8 (11.1) |
Most severe past episode | 44.9 (12.9) |
Highest in prior year | 59.7 (11.1) |
No. (%) | |
Sex | |
Female | 33 (56.9) |
Race | |
African American | 1 (1.7) |
Native American | 1 (1.7) |
Asian/Pacific Islander | 1 (1.7) |
Biracial | 3 (5.2) |
Hispanic ethnicity | 3 (5.2) |
Live with both biological parents | 26 (44.8) |
Bipolar I | 38 (65.5) |
Bipolar II | 6 (10.3) |
Bipolar not otherwise specified | 14 (24.1) |
Index mood episode | |
Depression | 18 (31.0) |
Mania | 12 (20.7) |
Mixed | 3 (5.2) |
Subthresholdc | 25 (43.1) |
Comorbid disorders | |
Anxiety | 2 (3.5) |
ADHD | 11 (19.0) |
ODD | 7 (12.1) |
Substance abuse or dependence | 0 (0.0) |
Medication treatments at study entry | |
1 mood stabilizer | 35 (60.0) |
2 mood stabilizers | 9 (15.5) |
1 atypical antipsychotic | 34 (58.6) |
2 atypical antipsychotics | 7 (12.1) |
Adjunctive antidepressant | 13 (22.4) |
Adjunctive anxiolytic | 3 (5.2) |
Type of mood stabilizer at study entry | |
Divalproex sodium | 7 (12.1) |
Lithium | 21 (36.2) |
Lamotrigine | 3 (5.2) |
Carbamazepine | 1 (1.7) |
Oxcarbazepine | 13 (22.4) |
Topiramate | 3 (5.17) |
Type of antipsychotic at baseline | |
Aripiprazole | 10 (17.2) |
Risperidone | 8 (13.8) |
Quetiapine | 21 (36.2) |
Olanzapine | 4 (6.9) |
Abbreviations: ADHD, attention deficit hyperactivity disorder; CGAS, Children's Global Assessment Scale; K-SADS, Kiddie Schedule for Affective Disorders and Schizophrenia; ODD, oppositional defiant disorder.
None of these variables significantly distinguished between the psychosocial treatment groups or sites, based on Mantel-Haenszel χ2 and 2-way analysis of variance tests.
Refers to scores collected at entry into the study, covering the worst 1- to 2-week period in the previous 3 months.
Adolescents with subthreshold index mood episodes had at least 1 to 2 weeks in the past 3 months with Adolescent Longitudinal Interval Follow-up Evaluation mania or depression scores ≥3 and <5.